OPC 21268
CAS: 131631-89-5
Ref. 3D-GFA63189
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Información del producto
- Acetamide, N-[3-[4-[[4-(3,4-dihydro-2-oxo-1(2H)-quinolinyl)-1-piperidinyl]carbonyl]phenoxy]propyl]-
- N-[3-(4-{[4-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)piperidin-1-yl]carbonyl}phenoxy)propyl]acetamide
- N-[3-[4-[4-(2-Oxo-1,2,3,4-tetrahydro-1-quinolinyl)piperidin-1-ylcarbonyl]phenoxy]propyl]acetamide
- N-[3-[4-[[4-(3,4-Dihydro-2-oxo-1(2H)-quinolinyl)-1-piperidinyl]carbonyl]phenoxy]propyl]acetamide
- Opc-21268
OPC 21268 is a drug used to treat chronic congestive heart failure. The drug works by increasing the concentration of cytosolic Ca2+ in cardiac myocytes, which leads to increased contractility and vasopressin secretion. OPC 21268 has been shown to be effective in experimental models of congestive heart failure. OPC 21268 causes vasoconstriction in the renal medulla, thereby increasing the glomerular filtration rate and reducing edema. This drug also has an effect on gland cells, leading to an increase in transcription-polymerase chain reaction activity and cellular proliferation.
Propiedades químicas
Consulta técnica sobre: 3D-GFA63189 OPC 21268
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
